MetaCap

Humacyte Statistics

NASDAQ: HUMAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.4454-0.0971 (-17.90%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Humacyte by the numbers

Humacyte has a market capitalization of $123.7 million based on 277.80M shares outstanding. With trailing EPS of $-0.45, Humacyte is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.4% below its 50-day average and 42.0% below its 200-day average.

Average daily trading volume is 5.36M shares, or about $2.4 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

HUMA valuation vs. peer median

HUMA compared with the median of 8 peer companies
MetricHUMAPeer medianDifference
Market cap$123.73M$119.31M+4%
Avg. volume5.36M1.16M+362%

Peer median across 8 companies: CMPX, IVVD, ENGN, ARMP, FATE, CRDL, TARA, STRO.

Valuation

Market cap
$123.73M
Price / sales (latest FY)
60.71
EPS (TTM)
$-0.45

Price and trading

Previous close
0.5425
Open
0.513
Day range
0.4444 – 0.52
52-week range
0.337 – 1.53
52-week change
-63.49%
Beta
—
Volume
5.77M

Dividends and events

Annual dividend
None
Next earnings date
Nov 10, 2026

Additional statistics

Market Cap
123.73M
Forward Pe
-1.78
Eps
-0.45
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
1.53
Week52 Low
0.34
Avg Volume
5.36M
Shares Outstanding
277.80M
Ma50
0.49
Ma200
0.77
Earnings Date
Nov 10, 2026
Pct From52w High
-70.79%
Pct From52w Low
32.17%

Related